Thromboelastography maximum amplitude predicts short‑term mortality in patients with hepatitis B virus‑related acute‑on‑chronic liver failure

Zhu,Zhe; Yu,Yong; Ke,Yefang; Deng,Danfei; Zheng,Guodong; Hua,Xin; Gao,Guosheng

doi:10.3892/etm.2020.8990

Thromboelastography maximum amplitude predicts short‑term mortality in patients with hepatitis B virus‑related acute‑on‑chronic liver failure

Authors:
- Zhe Zhu
- Yong Yu
- Yefang Ke
- Danfei Deng
- Guodong Zheng
- Xin Hua
- Guosheng Gao
View Affiliations

Affiliations: Department of Blood Transfusion, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315010, P.R. China, Department of Clinical Laboratory, Ningbo Women and Children's Hospital, Ningbo, Zhejiang 315012, P.R. China , Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315010, P.R. China
Published online on: July 13, 2020 https://doi.org/10.3892/etm.2020.8990
Pages: 2657-2664
Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Patients with hepatitis B virus (HBV)‑related acute‑on‑chronic liver failure (ACLF) exhibit complex hemostatic defects. Thromboelastography (TEG) can be used to reveal global hemostasis in patients with liver disease; however, little is known about the association between TEG and the outcome of patients with HBV‑related ACLF. The present study aimed to investigate the value of TEG for predicting 90 day mortality in patients with HBV‑related ACLF. A total of 51 patients with HBV‑related ACLF, 26 patients with chronic hepatitis B (CHB) and 26 healthy controls (HC) were enrolled in the present study. TEG, standard coagulation tests, routine blood tests, biochemical markers and demographic variables were recorded and assessed for prognostic value. The results indicated that a prolonged reaction and kinetics (K) time, a shortened α angle and a decreased maximum amplitude (MA) and coagulation index (CI) were observed in patients with HBV‑related ACLF, compared with CHB and HC subjects. Patients with HBV‑related ACLF in the mortality group exhibited a decrease in α angle, MA, lysis at 30 min, CI, fibrinogen and platelet count, and an increase in K time, international normalized ratio (INR) and the model for end‑stage liver disease (MELD) score in comparison with the survival group. MA and INR were two independent predictors of 90 day mortality in patients with HBV‑related ACLF, with hazard ratios of 0.918 (95% CI, 0.867‑0.971; P=0.003) and 3.141 (95% CI, 1.843‑5.354; P<0.001) respectively. When predicting 90 day mortality, MA + INR exhibited the highest area under the receiver operating characteristic curve, followed by INR, MELD score and MA. Patients with ACLF and MA ≤51.5 mm exhibited a poorer outcome than those with MA >51.5 mm, as revealed via the Kaplan‑Meier analysis. In summary, the findings of the present study suggested that TEG MA was associated with 90 day mortality in patients with HBV‑related ACLF, and a combination of MA and INR was superior to MA, INR and MELD score in terms of prognostic value.

View Figures

View References

1	Zhao RH, Shi Y, Zhao H, Wu W and Sheng JF: Acute-on-chronic liver failure in chronic hepatitis B: An update. Expert Rev Gastroenterol Hepatol. 12:341–350. 2018.PubMed/NCBI View Article : Google Scholar
2	Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, Durand F, Angeli P, Caraceni P, et al: CANONIC study investigators of the EASL-CLIF Consortium: Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 61:1038–1047. 2014.PubMed/NCBI View Article : Google Scholar
3	Wu T, Li J, Shao L, Xin J, Jiang L, Zhou Q, Shi D, Jiang J, Sun S, Jin L, et al: Chinese Group on the Study of Severe Hepatitis B (COSSH): Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 67:2181–2191. 2018.PubMed/NCBI View Article : Google Scholar
4	Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan AC, Chawla YK, Dokmeci AK, Garg H, Ghazinyan H, et al: APASL ACLF Working Party: Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int. 8:453–471. 2014.PubMed/NCBI View Article : Google Scholar
5	Chau TN, Chan YW, Patch D, Tokunaga S, Greenslade L and Burroughs AK: Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut. 43:267–271. 1998.PubMed/NCBI View Article : Google Scholar
6	Shin KH, Kim IS, Lee HJ, Kim HH, Chang CL, Hong YM, Yoon KT and Cho M: Thromboelastographic Evaluation of Coagulation in Patients With Liver Disease. Ann Lab Med. 37:204–212. 2017.PubMed/NCBI View Article : Google Scholar
7	Tripodi A and Mannucci PM: The coagulopathy of chronic liver disease. N Engl J Med. 365:147–156. 2011.PubMed/NCBI View Article : Google Scholar
8	Hawkins RB, Raymond SL, Hartjes T, Efron PA, Larson SD, Andreoni KA and Thomas EM: Review: The perioperative use of thromboelastography for liver transplant patients. Transplant Proc. 50:3552–3558. 2018.PubMed/NCBI View Article : Google Scholar
9	Wang SC, Shieh JF, Chang KY, Chu YC, Liu CS, Loong CC, Chan KH, Mandell S and Tsou MY: Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: Randomized clinical trial. Transplant Proc. 42:2590–2593. 2010.PubMed/NCBI View Article : Google Scholar
10	De Pietri L, Bianchini M, Montalti R, De Maria N, Di Maira T, Begliomini B, Gerunda GE, di Benedetto F, Garcia-Tsao G and Villa E: Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial. Hepatology. 63:566–573. 2016.PubMed/NCBI View Article : Google Scholar
11	Trautman CL, Palmer WC, Taner CB, Canabal JM, Getz T, Goldman A, Heckman MG, Diehl NN, Lee DD and Stancampiano FF: Thromboelastography as a Predictor of Outcomes Following Liver Transplantation. Transplant Proc. 49:2110–2116. 2017.PubMed/NCBI View Article : Google Scholar
12	Premkumar M, Saxena P, Rangegowda D, Baweja S, Mirza R, Jain P, Bhatia P, Kumar G, Bihari C, Kalal C, et al: Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure: An observational cohort study. Liver Int. 39:694–704. 2019.PubMed/NCBI View Article : Google Scholar
13	Blasi A, Calvo A, Prado V, Reverter E, Reverter JC, Hernández-Tejero M, Aziz F, Amoros A, Cardenas A and Fernández J: Coagulation failure in patients with acute-on-chronic liver failure and decompensated cirrhosis: Beyond the international normalized ratio. Hepatology. 68:2325–2337. 2018.PubMed/NCBI View Article : Google Scholar
14	Shi Y, Yang Y, Hu Y, Wu W, Yang Q, Zheng M, Zhang S, Xu Z, Wu Y, Yan H, et al: Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology. 62:232–242. 2015.PubMed/NCBI View Article : Google Scholar
15	Lin W, Zhang J, Liu X, Liu H, He J, Li M, Zhang S, Zhang Y, Chen H, Zhang C, et al: A Dynamic model for predicting outcome in patients with HBV related acute-on-chronic liver failure. Ann Hepatol. 17:392–402. 2018.PubMed/NCBI View Article : Google Scholar
16	Peng Y, Qi X, Tang S, Deng H, Li J, Ning Z, Dai J, Hou F, Zhao J, Wang R, et al: Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure. Expert Rev Gastroenterol Hepatol. 10:971–980. 2016.PubMed/NCBI View Article : Google Scholar
17	Stravitz RT: Potential applications of thromboelastography in patients with acute and chronic liver disease. Gastroenterol Hepatol (NY). 8:513–520. 2012.PubMed/NCBI
18	Reikvam H, Steien E, Hauge B, Liseth K, Hagen KG, Størkson R and Hervig T: Thrombelastography. Transfus Apheresis Sci. 40:119–123. 2009.PubMed/NCBI View Article : Google Scholar
19	Fisher C, Patel VC, Stoy SH, Singanayagam A, Adelmeijer J, Wendon J, Shawcross DL, Lisman T and Bernal W: Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure. J Crit Care. 43:54–60. 2018.PubMed/NCBI View Article : Google Scholar
20	Lloyd-Donald P, Vasudevan A, Angus P, Gow P, Mårtensson J, Glassford N, Eastwood GM, Hart GK and Bellomo R: Coagulation in acutely ill patients with severe chronic liver disease: Insights from thromboelastography. J Crit Care. 38:215–224. 2017.PubMed/NCBI View Article : Google Scholar
21	Goyal S, Jadaun S, Kedia S, Kumar-Acharya S, Varma S, Nayak B, Thakur B and M D S: Thromboelastography Parameters in Patients with Acute on Chronic Liver Failure. Ann Hepatol. 17:1042–1051. 2018.PubMed/NCBI View Article : Google Scholar
22	Dai J, Qi X, Li H and Guo X: Role of D-dimer in the development of portal vein thrombosis in liver cirrhosis: A meta-analysis. Saudi J Gastroenterol. 21:165–174. 2015.PubMed/NCBI View Article : Google Scholar
23	Li Y, Qi X, Li H, Dai J, Deng H, Li J, Peng Y, Liu X, Sun X and Guo X: D-dimer level for predicting the in-hospital mortality in liver cirrhosis: A retrospective study. Exp Ther Med. 13:285–289. 2017.PubMed/NCBI View Article : Google Scholar
24	Lisman T, Bakhtiari K, Adelmeijer J, Meijers JC, Porte RJ and Stravitz RT: Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure. J Thromb Haemost. 10:1312–1319. 2012.PubMed/NCBI View Article : Google Scholar
25	Leebeek FW and Rijken DC: The fibrinolytic status in liver diseases. Semin Thromb Hemost. 41:474–480. 2015.PubMed/NCBI View Article : Google Scholar
26	Stravitz RT, Ellerbe C, Durkalski V, Reuben A, Lisman T and Lee WM: Acute Liver Failure Study G. Thrombocytopenia is associated with multi organ system failure in patients with acute liver failure. Clin Gastroenterol Hepatol. 14:613–620 e614. 2016.PubMed/NCBI View Article : Google Scholar
27	Beilin Y, Arnold I and Hossain S: Evaluation of the platelet function analyzer (PFA-100) vs. the thromboelastogram (TEG) in the parturient. Int J Obstet Anesth. 15:7–12. 2006.PubMed/NCBI View Article : Google Scholar
28	Vinholt PJ, Hvas AM, Nielsen C, Söderström AC, Sprogøe U, Fialla AD and Nybo M: Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis. Platelets. 29:520–527. 2018.PubMed/NCBI View Article : Google Scholar
29	Shi X, Zhu P, Yan G, Liu C, Zhang C, Huang G, Zhang Y, Yan Z and Wang Y: Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure. J Viral Hepat. 23:920–929. 2016.PubMed/NCBI View Article : Google Scholar
30	Lisman T and Luyendyk JP: Platelets as modulators of liver diseases. Semin Thromb Hemost. 44:114–125. 2018.PubMed/NCBI View Article : Google Scholar
31	Li N, Huang C, Yu KK, Lu Q, Shi GF and Zheng JM: Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: The CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF. Medicine (Baltimore). 96(e6802)2017.PubMed/NCBI View Article : Google Scholar